| Dossier | Acheteur | Valeur | Attribué |
|---|---|---|---|
| Human Drug Advisory Panel260034 | Patented Medicine Prices Review Board Canada | 17 500 $ | 14 juill. 2026 |
| Scientific consultants240005 | Patented Medicine Prices Review Board Canada | 20 000 $ | 1 avr. 2024 |
| Scientific consultants230043 | Patented Medicine Prices Review Board Canada | 26 000 $ | 5 avr. 2023 |
| HDAP contract for 2022-23220044 | Patented Medicine Prices Review Board Canada | 22 000 $ | 19 avr. 2022 |
| Provision of specialized expertise in the drug evaluation and application of evidence-based medicine in the context of scientific review process for new and existing patented drug products.210047 | Patented Medicine Prices Review Board Canada | 17 000 $ | 1 avr. 2021 |
| Provision of specialized expertise in the drug evaluation and application of evidence-based medicine in the context of scientific review process for new and existing patented drug products.200065 | Patented Medicine Prices Review Board Canada | 17 725 $ | 1 avr. 2020 |